Company intelligence / Profile preview

Leica Biosystems

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

Leica Biosystems provides a comprehensive portfolio of anatomic pathology solutions spanning the entire workflow from biopsy to diagnosis. The company’s innovations include advanced slide production systems, staining automation, world-leading digital pathology with AI integration, and end-to-end workflow solutions. Their mission centers on advancing cancer diagnostics to improve patient outcomes. They enable over 1.6 million diagnoses weekly worldwide.

Therapeutic areas: Oncology
Modalities: DeviceDigital Pathology Platform
Industry: Pathology

Partnerships

Collaborates with hospitals/labs globally

Beyond the preview

Go deeper on Leica Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leica Biosystems.

Explore the full profile